Home NDC 69238-1135 Atazanavir
Product NDC 69238-1135
11-digit product format 692381135
Labeler code 69238
Product ID 69238-1135_0564f4f6-b4d0-477e-a730-93008830bef8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Atazanavir
Dosage form CAPSULE
Route ORAL
Labeler Amneal Pharmaceuticals NY LLC
Application ANDA209717
Marketing category ANDA
Marketing start 2020-06-03
Marketing end 0000-00-00
Substance ATAZANAVIR SULFATE
Active strength 100 mg/1
Pharmacologic classes Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209717-001 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 A209717-002 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 A209717-003 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 A209717-004 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 148 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2020-06-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2020-06-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2020-06-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209717-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL 2020-06-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A209717-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL 2020-06-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A209717-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL 2020-06-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A209717-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL 2020-06-01 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 81 observed states.
DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69238-1135 ATAZANAVIR CAPSULE [AMNEAL PHARMACEUTICALS NY LLC] 9 Legacy NDC 20250205_b670a844-3bbf-4d9a-9904-87992f26792d.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69238-1135-6 69238113506 60 CAPSULE in 1 BOTTLE (69238-1135-6) 60 capsule 2020-06-03 0000-00-00 No No Current